Literature DB >> 25894500

Fine mapping in the MHC region accounts for 18% additional genetic risk for celiac disease.

Javier Gutierrez-Achury1, Alexandra Zhernakova1, Sara L Pulit2, Gosia Trynka3, Karen A Hunt4, Jihane Romanos1, Soumya Raychaudhuri5, David A van Heel4, Cisca Wijmenga1, Paul I W de Bakker6.   

Abstract

Although dietary gluten is the trigger for celiac disease, risk is strongly influenced by genetic variation in the major histocompatibility complex (MHC) region. We fine mapped the MHC association signal to identify additional risk factors independent of the HLA-DQA1 and HLA-DQB1 alleles and observed five new associations that account for 18% of the genetic risk. Taking these new loci together with the 57 known non-MHC loci, genetic variation can now explain up to 48% of celiac disease heritability.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25894500      PMCID: PMC4449296          DOI: 10.1038/ng.3268

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


Celiac disease is an autoimmune disease triggered by the consumption of dietary gluten in which the primary organ affected is the small intestine. The major histocompatibility complex (MHC) is the main genetic factor in disease development, with the strongest effects mapped to the classical HLA-DQA1 and HLA-DQB1 genes. Specifically, the common haplotypes DQ2.5, DQ2.2 and DQ8 have been shown to increase disease risk by 6-fold on average[1,2]. Genome-wide association analyses have identified another 57 independent SNPs located in 39 risk loci outside the MHC[3,4]. In this study, we hypothesized that a substantial fraction of celiac disease heritability might be explained by unknown independent variants across the MHC (but outside the classical HLA-DQ region). These variants might have remained undetected in previous genome-wide association studies due to the complexities of fine-mapping association signals in the extended MHC region. We therefore imputed the region and tested for associated SNPs, amino acid polymorphisms, and classical HLA alleles in 12,016 cases and 11,920 controls of European ancestry (in six cohorts from five countries), all genotyped on the Illumina Immunochip array (Supplementary Table 1, Supplementary Methods). Because HLA class II haplotypes are established risk factors for celiac disease, we first focused on the region encompassing HLA-DRB1, HLA-DQA1 and HLA-DQB1. Consistent with functional studies, we confirmed strong associations for HLA-DQ (p = 10−177 for a direct comparison between all classical 4-digit alleles of HLA-DQA1/DQB1 and of HLA-DRB1; Supplementary Methods, Supplementary Table 2). We also observed remarkable allele frequency differences across European populations (Supplementary Table 3, Supplementary Fig. 1). In a step-wise conditional analysis within the HLA-DQ heterodimer molecule, we identified amino acid positions 25 and 47 in HLA-DQα1, and positions 57 and 74 in HLA-DQβ1, as the strongest independent associations with celiac disease risk (Supplementary Fig. 2, Supplementary Table 4). The haplotype model based on these four associated amino acid positions, of which β57 and β74 are thought to make direct contact with the epitope in the HLA-DQ binding groove, almost perfectly recapitulates the associations with the classical HLA-DQA1/DQB1 alleles (99.6% of the explained variance). For example, the haplotype defined by HLA-DQA1-Tyr25/Cys47 and HLA-DQB1-Ala57/Ala74 completely mirrors the risk conferred by HLA-DQ2.5 (amino acid haplotype OR=19.13, P= 10−1,754; HLA-DQ2.5 OR=21.56, P=10−1,801) (Supplementary Tables 2 and 4). In order to identify additional associations beyond HLA-DQ, we tested all the other variants across the MHC region after correcting for the collective effects of all classical HLA-DQA1 and DQB1 4-digit alleles. We identified five further independent variants with genome-wide significance: amino acid position 9 in HLA-DPβ1 (omnibus p = 10−41), classical alleles HLA-B*08:01 (p = 10−22) and HLA-B*39:06 (p = 10−8), and two SNPs, rs1611710 (p = 10−9) and rs2301226 (p = 10−9) (Fig. 1, Supplementary Fig. 3, Supplementary Table 5). eQTL analysis of publicly available datasets[5] demonstrated a cis-eQTL effect of rs1611710 on HLA-F expression (eQTL p = 1.22×10−56) and of rs2301226 on B3GALT4 (eQTL p = 1.67×10−39) and on HLA-DPB1 expression (eQTL p = 3.87×10−13). When we did not adjust a priori for the effects of HLA-DQ alleles, we found the same five independent effects, in addition to several strong effects in the class II region (Supplementary Fig. 4 and Supplementary Table 5), providing support for the robustness of these novel findings.
Figure 1

Schematic representation of the stepwise analysis applied in fine-mapping the HLA region. HLA-DQA1 and HLA-DQB1 4-digit alleles were included in the model to control for their effect (red arrow). A green flag represents each of the steps in the analysis and an independent association.

Based on all the genetic associations for celiac disease risk, we estimated the genetic variance explained (h2) with a liability threshold model, assuming a disease prevalence of 1%[6-10] (Table 1 and Supplementary Methods). The classical HLA-DQ loci alone explain h2 = 0.232 on the liability scale, whereas the five novel variants reported here explain an additional h2 = 0.180, which is more than twice that explained by the 57 independent SNPs outside the MHC[3] (h2 = 0.065). In total, all the variants identified to date as being robustly associated with celiac disease risk explain approximately h2 = 0.477. These liability estimates are more modest than those previously published (~87% explained genetic risk[11]). This discrepancy illustrates the difficulty of comparing explained variance estimates between studies if the model assumptions are not the same[12]. When we changed the assumed prevalence to 2% and 3%, as reported in some populations (Supplementary Methods), we observed substantially increased heritability estimates, which illustrates not only how sensitive the estimates are to this parameter, but also how estimates may change in populations with an empirically higher disease prevalence (Supplementary Table 6).
Table 1

Heritability estimates for HLA and non-HLA variants in celiac disease.

h2h2
ModelObserved scaleLiability scale
Classical HLA-DQ alleles (4-digit)0.3160.232
Independent MHC variants outside HLA-DQ0.3570.180
Non-MHC variants (57 SNPs)0.150.065

Combined0.8230.477
Although the importance of the MHC region in celiac disease and other autoimmune diseases is widely recognized, the particular properties of the region[13] have made it difficult to identify independent loci and pinpoint functional variants that play a role in disease pathology. Taking advantage of high-density imputation[14], we implicated a set of five variants (Fig. 1, Supplementary Figs. 2 and 3) that act independently of HLA-DQ and which can explain an additional 18% of celiac disease heritability. On the basis of these results, it seems likely that fine-mapping the MHC region in other diseases with classical HLA associations will reveal some of the “missing” heritability. Finally, this study provides evidence that the MHC class I region is also an important locus in celiac disease etiology. This is an interesting observation given the presumed role for intraepithelial lymphocytes (IELs) TCRαβ+CD8αβ+, which have been shown to exacerbate celiac disease and are restricted to MHC class I recognition[15]. These cells represent a subtype of antigen-experienced “innate-like” T cells and, under conditions of homeostasis, they are located within the intestinal mucosa, maintaining epithelium integrity and preventing pathogen incursion. The TCRαβ+CD8αβ+ are most abundant in the intestinal mucosa (70–80% of the IEL subset) and are a hallmark of celiac disease due to their correlation with gluten intake, thereby providing further support for the role of IELs in the etiology of celiac disease.
  15 in total

Review 1.  Intraepithelial lymphocytes in celiac disease immunopathology.

Authors:  Valérie Abadie; Valentina Discepolo; Bana Jabri
Journal:  Semin Immunopathol       Date:  2012-06-03       Impact factor: 9.623

2.  A better coefficient of determination for genetic profile analysis.

Authors:  Sang Hong Lee; Michael E Goddard; Naomi R Wray; Peter M Visscher
Journal:  Genet Epidemiol       Date:  2012-04       Impact factor: 2.135

3.  GCTA: a tool for genome-wide complex trait analysis.

Authors:  Jian Yang; S Hong Lee; Michael E Goddard; Peter M Visscher
Journal:  Am J Hum Genet       Date:  2010-12-17       Impact factor: 11.025

4.  Concordance, disease progression, and heritability of coeliac disease in Italian twins.

Authors:  L Nisticò; C Fagnani; I Coto; S Percopo; R Cotichini; M G Limongelli; F Paparo; S D'Alfonso; M Giordano; C Sferlazzas; G Magazzù; P Momigliano-Richiardi; L Greco; M A Stazi
Journal:  Gut       Date:  2005-12-14       Impact factor: 23.059

5.  Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease.

Authors:  Jihane Romanos; Cleo C van Diemen; Ilja M Nolte; Gosia Trynka; Alexandra Zhernakova; Jingyuan Fu; Maria Teresa Bardella; Donatella Barisani; Ross McManus; David A van Heel; Cisca Wijmenga
Journal:  Gastroenterology       Date:  2009-05-18       Impact factor: 22.682

Review 6.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases.

Authors:  Glinda S Cooper; Milele L K Bynum; Emily C Somers
Journal:  J Autoimmun       Date:  2009-10-09       Impact factor: 7.094

7.  Synthetic associations created by rare variants do not explain most GWAS results.

Authors:  Naomi R Wray; Shaun M Purcell; Peter M Visscher
Journal:  PLoS Biol       Date:  2011-01-18       Impact factor: 8.029

8.  Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease.

Authors:  Gosia Trynka; Karen A Hunt; Nicholas A Bockett; Jihane Romanos; Vanisha Mistry; Agata Szperl; Sjoerd F Bakker; Maria Teresa Bardella; Leena Bhaw-Rosun; Gemma Castillejo; Emilio G de la Concha; Rodrigo Coutinho de Almeida; Kerith-Rae M Dias; Cleo C van Diemen; Patrick C A Dubois; Richard H Duerr; Sarah Edkins; Lude Franke; Karin Fransen; Javier Gutierrez; Graham A R Heap; Barbara Hrdlickova; Sarah Hunt; Leticia Plaza Izurieta; Valentina Izzo; Leo A B Joosten; Cordelia Langford; Maria Cristina Mazzilli; Charles A Mein; Vandana Midah; Mitja Mitrovic; Barbara Mora; Marinita Morelli; Sarah Nutland; Concepción Núñez; Suna Onengut-Gumuscu; Kerra Pearce; Mathieu Platteel; Isabel Polanco; Simon Potter; Carmen Ribes-Koninckx; Isis Ricaño-Ponce; Stephen S Rich; Anna Rybak; José Luis Santiago; Sabyasachi Senapati; Ajit Sood; Hania Szajewska; Riccardo Troncone; Jezabel Varadé; Chris Wallace; Victorien M Wolters; Alexandra Zhernakova; B K Thelma; Bozena Cukrowska; Elena Urcelay; Jose Ramon Bilbao; M Luisa Mearin; Donatella Barisani; Jeffrey C Barrett; Vincent Plagnol; Panos Deloukas; Cisca Wijmenga; David A van Heel
Journal:  Nat Genet       Date:  2011-11-06       Impact factor: 38.330

9.  Risk of pediatric celiac disease according to HLA haplotype and country.

Authors:  Edwin Liu; Hye-Seung Lee; Carin A Aronsson; William A Hagopian; Sibylle Koletzko; Marian J Rewers; George S Eisenbarth; Polly J Bingley; Ezio Bonifacio; Ville Simell; Daniel Agardh
Journal:  N Engl J Med       Date:  2014-07-03       Impact factor: 176.079

10.  Systematic identification of trans eQTLs as putative drivers of known disease associations.

Authors:  Harm-Jan Westra; Marjolein J Peters; Tõnu Esko; Hanieh Yaghootkar; Claudia Schurmann; Johannes Kettunen; Mark W Christiansen; Bruce M Psaty; Samuli Ripatti; Alexander Teumer; Timothy M Frayling; Andres Metspalu; Joyce B J van Meurs; Lude Franke; Benjamin P Fairfax; Katharina Schramm; Joseph E Powell; Alexandra Zhernakova; Daria V Zhernakova; Jan H Veldink; Leonard H Van den Berg; Juha Karjalainen; Sebo Withoff; André G Uitterlinden; Albert Hofman; Fernando Rivadeneira; Peter A C 't Hoen; Eva Reinmaa; Krista Fischer; Mari Nelis; Lili Milani; David Melzer; Luigi Ferrucci; Andrew B Singleton; Dena G Hernandez; Michael A Nalls; Georg Homuth; Matthias Nauck; Dörte Radke; Uwe Völker; Markus Perola; Veikko Salomaa; Jennifer Brody; Astrid Suchy-Dicey; Sina A Gharib; Daniel A Enquobahrie; Thomas Lumley; Grant W Montgomery; Seiko Makino; Holger Prokisch; Christian Herder; Michael Roden; Harald Grallert; Thomas Meitinger; Konstantin Strauch; Yang Li; Ritsert C Jansen; Peter M Visscher; Julian C Knight
Journal:  Nat Genet       Date:  2013-09-08       Impact factor: 38.330

View more
  49 in total

1.  Functional implications of disease-specific variants in loci jointly associated with coeliac disease and rheumatoid arthritis.

Authors:  Javier Gutierrez-Achury; Maria Magdalena Zorro; Isis Ricaño-Ponce; Daria V Zhernakova; Dorothée Diogo; Soumya Raychaudhuri; Lude Franke; Gosia Trynka; Cisca Wijmenga; Alexandra Zhernakova
Journal:  Hum Mol Genet       Date:  2015-11-05       Impact factor: 6.150

2.  Coeliac disease &gluten sensitivity: Epithelial stress enters the dance in coeliac disease.

Authors:  Nadine Cerf-Bensussan; Bertrand Meresse
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-07-21       Impact factor: 46.802

Review 3.  The roles of MHC class II genes and post-translational modification in celiac disease.

Authors:  Ludvig M Sollid
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

4.  Ancestry-based stratified analysis of Immunochip data identifies novel associations with celiac disease.

Authors:  Koldo Garcia-Etxebarria; Amaia Jauregi-Miguel; Irati Romero-Garmendia; Leticia Plaza-Izurieta; Maria Legarda; Iñaki Irastorza; Jose Ramon Bilbao
Journal:  Eur J Hum Genet       Date:  2016-09-21       Impact factor: 4.246

5.  Allelic frequencies of the hs1.2 enhancer within the immunoglobulin heavy chain region in Dayton, Ohio patients screened for celiac disease with duodenal biopsy.

Authors:  Jing Liu; Rebecca A Law; Paul G Koles; Jonathan C Saxe; Michael Bottomley; Courtney E W Sulentic
Journal:  Dig Liver Dis       Date:  2017-04-09       Impact factor: 4.088

Review 6.  Mechanisms of gastrointestinal allergic disorders.

Authors:  Nurit P Azouz; Marc E Rothenberg
Journal:  J Clin Invest       Date:  2019-03-11       Impact factor: 14.808

7.  Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk.

Authors:  Jennie G Pouget; Buhm Han; Yang Wu; Emmanuel Mignot; Hanna M Ollila; Jonathan Barker; Sarah Spain; Nick Dand; Richard Trembath; Javier Martin; Maureen D Mayes; Lara Bossini-Castillo; Elena López-Isac; Ying Jin; Stephanie A Santorico; Richard A Spritz; Hakon Hakonarson; Constantin Polychronakos; Soumya Raychaudhuri; Jo Knight
Journal:  Hum Mol Genet       Date:  2019-10-15       Impact factor: 6.150

8.  Lower Prevalence of Celiac Disease and Gluten-Related Disorders in Persons Living in Southern vs Northern Latitudes of the United States.

Authors:  Aynur Unalp-Arida; Constance E Ruhl; Rok Seon Choung; Tricia L Brantner; Joseph A Murray
Journal:  Gastroenterology       Date:  2017-02-24       Impact factor: 22.682

Review 9.  Coeliac disease and autoimmune disease-genetic overlap and screening.

Authors:  Knut E A Lundin; Cisca Wijmenga
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-08-25       Impact factor: 46.802

10.  miRNA-regulated gene expression differs in celiac disease patients according to the age of presentation.

Authors:  Gaia Buoli Comani; Roberto Panceri; Marco Dinelli; Andrea Biondi; Clara Mancuso; Raffaella Meneveri; Donatella Barisani
Journal:  Genes Nutr       Date:  2015-08-02       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.